Ordinary investors now hold a direct path to owning shares in private startups, yet that path comes loaded with everything from outright business collapse to shares they cannot easily sell. A handful of equity crowdfunding platforms have turned early-stage fundraising into a global marketplace, bypassing stock exchanges entirely.
The stakes have never been higher. Private markets once belonged to venture capital firms and wealthy individuals. Meanwhile, platforms like Crowdcube and StartEngine now let everyday backers fund companies across Europe, the United States, and beyond, shifting who gets to shape tomorrow’s businesses.
Crowdcube leads globally with roughly USD 2.2 billion raised. Headquartered in the UK, it backs consumer brands, food ventures, fintech, and software companies. Investors buy direct equity through its structure, but every campaign carries its own entry rules and risk profile.
Republic Europe, previously called Seedrs, sits near the top with about USD 1.6 billion. Its strength lies in early-stage and growth-focused European businesses. As a result, backers should study nominee arrangements, valuations, share rights, and exit conditions before committing funds.
StartEngine, a US platform with around USD 551.1 million raised, covers technology, entertainment, and consumer products. Deals operate under Regulation Crowdfunding and Regulation A+, giving eligible private firms structured ways to raise capital. Republic, another US player, has recorded USD 293.4 million across startups, gaming, technology, and select alternative assets.
Wefunder follows with USD 244.8 million, focusing on healthcare, sustainability, consumer goods, and technology. It ran 275 US Reg CF campaigns in the twelve months ending October 2026. Sowefund, meanwhile, holds roughly USD 230 million and directs capital toward French startups, especially those with social or environmental missions.
Italian deal flow flows through Mamacrowd, which has raised USD 217.1 million for local startups and tech ventures. Capital Cell, comparatively niche, concentrates on biotech, medtech, and life sciences. Its USD 187.8 million record underscores investor appetite for long-term scientific bets despite regulatory hurdles and clinical trial delays.
Blast.club and Tudigo round out the list with USD 157.4 million and USD 140.3 million respectively. Blast.club spans European private companies, while Tudigo concentrates on French startups and regional businesses with strong community ties.
Regulatory gaps complicate cross-border investing. US Regulation Crowdfunding permits eligible companies to raise up to USD 5 million annually. The European Crowdfunding Service Provider framework generally caps project owners at EUR 5 million over twelve months. Indian investors, for their part, must sort through foreign exchange rules, tax obligations, and platform access limits before sending any money abroad.
Platform rankings reveal little about investment quality. Startup shares can crater to zero, and private holdings often prove difficult to offload. Company accounts, fee structures, share rights, and realistic exit expectations deserve far more scrutiny than cumulative fundraising totals.















